SCHEMBL3924255

SCHEMBL3924255

CCCCCCCCCCOc1ccc(OCC2CO2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.59
TDP1 Q9NUW8 2/20 0.59
TP53 P04637 4/20 0.57
TSHR P16473 4/20 0.57
MAPT P10636 2/20 0.57
HPGD P15428 2/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
HIF1A Q16665 2/20 0.57
CYP1A2 P05177 1/20 0.57
PPARG P37231 1/20 0.57
NR5A1 Q13285 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.53
PKM P14618 2/20 0.53
LMNA P02545 1/20 0.53
GAA P10253 1/20 0.53
LTA4H P09960 3/20 0.50
CYP3A4 P08684 1/20 0.50
PLA2G4B P0C869 1/20 0.47
NPC1 O15118 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7556434 1.00 ALDH1A1 (0.59) ALDH1A1TDP1TP53TSHRMAPT
SCHEMBL7556427 1.00 ALDH1A1 (0.59) ALDH1A1TDP1TP53TSHRMAPT
SCHEMBL28659990 1.00 ALDH1A1 (0.59) ALDH1A1TDP1TP53TSHRMAPT
SCHEMBL10419046 0.98 ALDH1A1 (0.58) ALDH1A1TDP1TP53TSHRMAPT
SCHEMBL7120531 0.95 ALDH1A1 (0.62) ALDH1A1TDP1TP53TSHRMAPT
SCHEMBL11714028 0.95 ALDH1A1 (0.62) ALDH1A1TDP1TP53TSHRMAPT
SCHEMBL19607361 0.95 ALDH1A1 (0.62) ALDH1A1TDP1TP53TSHRMAPT
SCHEMBL22092652 0.91 TDP1 (0.66) ALDH1A1TDP1TP53TSHRMAPT
SCHEMBL22092171 0.91 TDP1 (0.66) ALDH1A1TDP1TP53TSHRMAPT
SCHEMBL10836633 0.88 ALDH1A1 (0.62) ALDH1A1TDP1TP53TSHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7608633-B2 Heteroaryl-substituted acetone derivatives as inhibitors of phospholipase A2 MERCKLE GMBH (DE) 2009-10-27 US disclosed
EP-1590324-B1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb MERCKLE GMBH (DE) 2009-03-11 EP disclosed
US-20060142366-A1 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 MERCKLE GMBH (DE) 2006-06-29 US disclosed
EP-1590324-A1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A sb 2 /sb MERCKLE GMBH (DE) 2005-11-02 EP disclosed
WO-2004069797-A1 NOVEL HETEROARYL-SUBSTITUTED ACETONE DERIVATIVES AS INHIBITORS OF PHOSPHOLIPASE A2 MERCKLE GMBH (DE) 2004-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142366-A1 Novel heteroaryl-substituted acetone derivatives as inhibitors of phospholipase a2 PLD2, PLA2G1B, PLA2G4A ALDH1A1 883/4885TDP1 2434/4885TP53 3043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.